Trial Profile
A Long-term Extension Study of GI198745 in Subjects With Benign Prostatic Hyperplasia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 07 Sep 2009 New trial record